Alaunos Therapeutics, Inc. (TCRT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 0.96 |
| Open | 0.95 |
| Day High | 1 |
| Day Low | 0.85 |
| 52-Week High | 4.59 |
| 52-Week Low | 0.85 |
| Volume | 90,034 |
| Average Volume | 797,982 |
| Market Cap | 2.17M |
| PE | -0.46 |
| EPS | -1.95 |
| Moving Average 50 Days | 1.68 |
| Moving Average 200 Days | 2.52 |
| Change | -0.07 |
Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders
GlobeNewswire Inc.
Mar 02, 2026 11:30 AM GMT
The lead drug candidate, ALN1003, showed dose-related body weight loss and favorable body composition changes in the DIO mouse modelALN1003 also demonstrated reductions in liver weight and improvements in select biomarkers associated with liver injur